- Home
- » Tags
- » Perhexiline
Top View
- A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information
- Medicines for Cardiovascular Health
- The Natural History of Histologically Proved Drug Induced Liver Disease Gut: First Published As 10.1136/Gut.44.5.731 on 1 May 1999
- Cytochrome P450 Drug Interaction Table
- Investigation Into in Vitro Anti-Leishmanial Combinations of Calcium Channel Blockers and Current Anti-Leishmanial Drugs
- Impaired Oxidation of Debrisoquine in Patients with Perhexiline Liver Injury
- New Zealand Data Sheet
- GLEEVEC) in Patients with HIV Related Kaposi's Sarcoma
- Customised in Vitro Model to Detect Human Metabolism-Dependent
- Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
- ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
- TG Gates: a Large-Scale Transcriptomics and Pathology Database Florian Caiment
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Of 33 Appendix
- Polymorphic Hydroxylation of Perhexilinemaleate
- Title a Phase 2, Multi-Center, Open-Label, Ascending Dose Study
- Drug Consumption Databases in Europe
- In Vitro to in Vivo Extrapolation for Drug-Induced Liver Injury Using a Pair Ranking Method
- Perhexiline Demonstrates FYN-Mediated Antitumor Activity in Glioblastoma Shiva Kant1, Pravin Kesarwani1, Anthony R
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Pharmacological Approaches of Refractory Angina
- Shared Molecular Signatures Across Neurodegenerative Diseases And
- TDM of Drugs with Non-Linear* Pharmacokinetics
- Improvement in Cardiac Energetics by Perhexiline in Heart Failure Due to Dilated Cardiomyopathy
- Inhibition of Fatty Acid Oxidation As a New Target to Treat Primary Amoebic
- Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
- ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
- Guide to Therapeutic Drug Monitoring
- Structured Literature Review of Hepatic Toxicity Caused by Medicines
- Which Drug Class and Why?
- Known Bioactives Library: Prestwick 2 Collection
- Customs Tariff - Schedule
- Marshalling the Human Genome to Individualise Drug Therapy
- Compound Name Matrix Methodology
- Study Protocol Calcium Channel Blocker Treatments and Cancer Risk
- Fatty Liver and Drugs: the Two Sides of the Same Coin
- An Application to Include Blood Pressure Lowering Drug Fixed Dose
- Nsw Health Pathology 2018 - August Update
- Ethanol 40 L-Glutamic Acid 39 Zonisamide 30 Picrotoxin 22
- (12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
- Inhibition of Human Platelet Aggregation by Perhexiline Maleate: Mechanisms and Therapeutic Implications
- Drug Consumption Databases in Europe
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- WO 2007/016766 Al
- Carnitine in the Treatment of Valproic Acid-Induced Toxicity – What Is the Evidence? Philippe ER Lheureux, Andrea Penaloza, Soheil Zahir and Mireille Gris